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Abstract
Background: Chlamydia prevalence in the Netherlands remains high despite targeted efforts. Effective Partner
Notification (PN) and Partner Treatment (PT) can interrupt transmission and prevent re-infections. Patient Initiated Partner
Treatment (PIPT) may strengthen chlamydia control. This study explores the current practice of PN and PT, and benefits
of, and barriers and facilitators for PIPT among professionals in sexual health care in the Netherlands.
Methods: A qualitative study was performed among GPs, GP-assistants (GPAs), physicians and nurses working
at Sexual Health Clinics (SHC) and key-informants on ethnical diversity using topic lists in focus groups (N = 40) and semi-
structured questionnaires in individual interviews (N = 9). Topics included current practices regarding PN and PT, attitude
regarding PIPT, and perceived barriers and facilitators for PIPT. Interviews were taped, transcribed verbatim,
and coded using ATLAS.ti. A quantitative online questionnaire on the same topics was sent to all physicians
and nurses employed at Dutch SHC (complete response rate 26% (84/321)).
Results: The qualitative study showed that all professionals support the need for more attention to PN, and
that they saw advantages in PIPT. Mentioned barriers included unwilling PN-behaviour, Dutch legislation,
several medical considerations and inadequate skills of GPs. Also, concerns about limited knowledge of
cultural sensitivity around PN and PT were raised. Mentioned facilitators of PIPT were reliable home based
test-kits, phone-contact between professionals and notified partners, more consultation time for GPs or
GPAs and additional training. The online questionnaire showed that SHC employees agreed that partners
should be treated as soon as possible, but also that they were reluctant towards PIPT without counselling
and testing.
Conclusions: Professionals saw advantages in PIPT, but they also identified barriers hampering the potential
introduction of PIPT. Improving PN and counselling skills with specific focus on cultural sensitivity is needed. PIPT could
be considered for specific partners. PIPT in combination with home based testing and using e-healthcare should be
further explored and developed.
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Background
Chlamydia re-infections are common and increase
risk of complications and adverse reproductive
outcomes [1, 2]. About one third of chlamydia re-
infections in heterosexuals are caused by untreated
partners [2–4], stressing the importance of Partner
Notification (PN) and Partner Therapy (PT), in STI
control [5, 6].
Expedited Partner Therapy (EPT) allows health care
providers to provide STI-patients with a prescription or
antibiotics for their sex partner(s) without an intervening
medical evaluation of the partner(s) [7]. This can be
done by handing out medication to the partner by the
index-case, (Patient Delivered Partner Therapy (PDPT))
[8, 9], or by providing an accelerated prescription for the
partner with medical history gained through a
telephone-hotline or at a pharmacy (Accelerated Partner
Therapy (APT)) [10, 11]. EPT is efficacious in reducing
re-infections in index patients and increasing the num-
ber of partners treated [8, 12]. In the USA EPT is per-
missible in 38 states and potentially allowable in 11
states [13]. Still, uptake of EPT was around 50% in stud-
ies [14]. In the UK APT is seen as a viable option, but
did not achieve high uptake in practice [10, 11, 15].
In the Netherlands EPT as practiced in the US is cur-
rently not allowed by law. Dutch guidelines advise PN
for chlamydia for all partners in the last 6 months, and
to treat current and most recent ex-partners presump-
tively, without awaiting test-results [16, 17]. However, as
chlamydia prevalence remains high in the Netherlands
despite targeted PN efforts, the use of EPT could be of
substantial benefit.
In 2016, the project investigating options for Patient
Initiated Contact treatment for Chlamydia in the
Netherlands (PICC-UP) started, to investigate the poten-
tial of EPT and/or APT as an effective method for im-
proving PT in heterosexual patients. In this study we
define ‘Patient Initiated Partner Treatment’ (PIPT),
which can include both EPT or APT. One aim was to
gain insight into the current practice of PN and PT and
into opinions regarding benefits of, and barriers and fa-
cilitators for PIPT among professionals in sexual health
care in the Netherlands. Furthermore, as chlamydia is
more common in specific migrant groups [18] we
explored views about PN and beliefs, norms and accept-
ability of PIPT among these groups in key-informants
from various cultural backgrounds.
Sexual health care in the Netherlands is mostly carried
out through the general practitioners (GP), who do 2/3
of all STI consultations. Additionally, Sexual Health
Clinics (SHC) provide free of charge care for high-risk
groups. In this investigation, we use a qualitative study
among health staff in GP-practices and SHC, and among
key-informants with various ethnic/migratory origins
and a quantitative survey among physicians and nurses
in SHC to describe current practice as well as opinions
and beliefs regarding PN, PT and PIPT in Dutch sexual
health care.
Methods
Qualitative study
Recruitment
We performed focus group discussions with SHC
professionals (physicians and nurses) from various
clinics and geographical areas who were recruited via
their professional association. GPs were recruited for
focus group discussions during a national meeting of all
GPs specialized in sexual health care and additional indi-
vidual interviews were held with GPs and practice assis-
tants (GPAs) from both urban and more remote areas.
Furthermore, group- and individual interviews were held
with eight key informants with various cultural back-
grounds, including experienced peer educators in a sex-
ual health programme from the Municipal Public Health
Service Rotterdam-Rijnmond. Table 1 shows information
on gender and migratory background of the participants.
Data collection and analyses
Current practice of PN and PT was assessed with
examples from practice. A semi structured topic list was
developed based on literature, covering attitude towards
PIPT, potential barriers and facilitators, and questions
about possible options for PIPT in the Dutch situation.
The predefined topics were discussed in each focus
group (1–1.5 h) under the guidance of one facilitator
and one observer. The individual interviews (30 min)
were conducted either face to face or by phone, in ac-
cordance with the availability of the professionals. Data
collection took place in the period January – June 2016.
All interviews and focus group discussions were taped
with consensus of the professionals and transcribed ver-
batim. The transcriptions were coded and analysed by
AN and JO, with ATLAS.Ti 7 software for qualitative re-
search. We opted for an inductive thematic analysis
starting with a close line-by-line reading of the tran-
script, and developing from there, a conceptual or cod-
ing scheme. For triangulation purposes, the data were
analysed individually by AN and JO and both themes
and findings were discussed with AW and HG. The
coded material, the analyses and the results were dis-
cussed by all authors.
Quantitative survey
An online, anonymous, questionnaire was sent in
September 2016 to all 73 physicians and 248 nurses
employed at the 24 Dutch SHC. A reminder could
not be sent. The questionnaire was self-developed
and based on results of the qualitative study, and
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included seven-point Likert-type scale questions on
current practice of PN and PT as well as on opin-
ions and attitudes towards PIPT. The questionnaire
was piloted with several research colleagues. Descrip-
tive analyses were performed. Answers to the ques-
tions were summarised into disagreement (1–3
points) and agreement (5–7 points) versus neutral (4
points). Percentages were calculated excluding miss-
ing values.
Results
Qualitative study
The qualitative study included 25 GPs, 3 GPAs, 8 SHC-
physicians, 5 SHC-nurses, and 8 key-informants (see
Table 1 for characteristics of participants).
Current practice regarding PN
All professionals indicated to inform their patients about
the diagnosis, treatment and preventive advice including
a period to abstain from sexual contact. The SHC pro-
fessionals applied multiple strategies to stimulate PN:
giving factual information, counselling, motivational
interviewing, and addressing the need of responsibility
for the health of patient and partners in an understand-
ing and sympathetic manner. These strategies were also
named by the 3 GPAs interviewed and by some, but not
all, GPs.
‘Motivational interviewing can help you get closer to a
solution step by step. It often works better, because every
step comes from the patient. We as professionals can give
all kind of advice, but if a patient doesn’t get it, then it
just won’t work’ (GPA, female, Dutch).
Professionals address the responsibility of patients for
their own and their partner’s health. While some GPs
use an authoritarian way, others prefer another style:
One GP explains: ‘I do not think it will work to tell pa-
tients that they must notify partners. I rather tell them
that they may have infected partners and explain about
complications to motivate them to take their responsibili-
ty’(GP, female, Dutch).
SHC and GP-practice professionals all have access to
the PN-website “www.partnerwaarschuwing.nl” to support
PN [19]. SHC health workers use this site regularly, as well
as some GPAs.
Cultural differences in PN
The interviewed key-informants on ethnical diversity
stressed that there should be more awareness among
health professionals regarding differences between pa-
tients of various migratory origins regarding PN. They
explained that the social pressure among people of
Turkish, Moroccan and Hindustani origin is high when
the honour of the family is at stake. Sometimes patients
may therefore prevail their honour over their health.
‘Turkish people don’t just marry a woman, they marry a
family. They’ll consider everything. They would tell it
[red: diagnosis of STI] one to one, but the family circle
makes it difficult’ (Key informant, male, Turkish).
The Cape Verdean, Antillean and Surinamese key-
informants indicated to experience a lower barrier for
PN, because they are more open about sexuality than
Moroccans or Turks. Within all mentioned migrant
groups, men talk easier about STIs than women. There
are in-group differences between generations and be-
tween people with and without a migration background.
Key-informants mentioned that second generation
young Turks and Cape Verdeans often disapprove of
adultery. First generation Turks exhibit avoidance behav-
iour to prevent a divorce. Both attitudes are a barrier for
PN. For younger Cape Verdeans extramarital sexual con-
tacts are taboo, while multiple sexual contacts are
viewed as experimental behaviour in youngsters not yet
married, which makes PN less difficult for the latter
group. Despite differences between and within groups,
all key-informants had the impression that patients with
a migratory origin tend to avoid PN.
Current practice regarding PT for chlamydia
At the SHC, notified partners have high priority in the
triage and are tested following test-guidelines. Those no-
tified by a current partner are offered treatment at first
consultation, before test-results are known, usually as
observed therapy and in some clinics through a prescrip-
tion. Notified partners who consult their GP are often –
though not always – tested before treatment. The
Table 1 Study population of qualitative study
Profession Focus group Individual Total Sex (F/M) Migratory background
GPs 21 4 25 11/14 Dutch
GPAs 0 3 3 3/0 2 Dutch, 1 Turkish
SHC physicians 8 0 8 4/4 Dutch
SHC nurses 4 1 5 5/0 Dutch
Key-informants on ethnic diversity# 7 1 8 4/4 Diverse a
TOTAL 40 9 49 27/ 22
aThe key-informants were Turkish (2 M), Surinamese (Creole and Hindustani) (1 M, 2 F), Antillean (1 F), Cape Verdean (1 M) and Dutch (1 F)
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majority of GP-practices limit their PT to the regular
partner, and only when partner and index are registered
at the same practice, because then the medical history of
the partner is known. As a GP said:
‘As a doctor we are responsible when we prescribe anti-
biotics and something goes wrong. That is a reason why
we don’t prescribe for patients who are not registered
with us’ (GP, female, Dutch).
Despite several objections, GPs sometimes prescribe
extra antibiotics for uninsured partners or when the
patient finds PN too difficult. For example, if the patient
fears domestic violence or - within certain migrant
groups - honour related violence:
‘If their safety is endangered, I give them an extra dose.
The patients then put pills in the yogurt or tell the spouse
that it’s for a sore throat’ (GP, female, Dutch). This anec-
dotal quote as well as information from key informants
showed that in extreme cases professionals search for
ways to prevent re-infection of their patients outside any
guideline.
General attitude regarding PIPT
All professionals saw several advantages in the use of
PIPT. They thought that PIPT would treat more
chlamydia infections in partners and consequently
decrease the number of re-infections. Another advantage
would be that partners who fail to get tested would be
treated. Also, costs for testing may be avoided. However,
the positive attitude of most professionals was quickly
followed by a list of barriers and questions concerning
how PIPT could be arranged in a legal and responsible
way.
Professionals’ perceived barriers to using PIPT
Patients’ PN behaviour The most mentioned barrier
for PIPT concerned patients’ PN-behaviour. Execution of
PN usually depends completely on the patient. Profes-
sionals mentioned that shame, fear, feelings of guilt and
lack of motivation often stand in the way of PN. Patients
with casual sex contacts often lack motivation to notify
their partners or do not have contact information. GPs
and GPAs mentioned a lack of ways to apply current
partner immediately to enforce PN. Professionals can
only notify a partner after the patient provides contact
details of a partner and asks them to notify the partner,
and only notified partners can be given PIPT.
Professionals’ knowledge and competencies Several
GPs and GPAs noted that GPs might need more specific
training to talk about PN and PT, as some GPs feel un-
comfortable discussing sexual issues with patients. One
GP noted that younger GPs manage to discuss sexual is-
sues easier:
‘Young colleagues feel more at ease in talking about
sexual issues. The young GP found a number of chla-
mydia infections by asking those patients uninhibitedly
about their sex life and advising them a test. The older
GP had no idea that these patients might be infected.’
(GP, male, Dutch).
Some professionals thought that some GPs may not
have enough knowledge on STIs and therefore do not
provide their patients with crucial advice.
‘I give a lot of training to GPs. When I ask: ‘How long
should someone withhold from sex?’That’s when they ask
me: ‘Can’t they have sex right away?’ (SHC physician fe-
male, Dutch).
Especially the GPAs mentioned the need for training
of GPs in counselling and motivational interviewing, in
giving the right information, addressing responsibility in
a non-judgemental way, and referring patients to “part-
nerwaarschuwing.nl”.
The key-informants additionally suggested communi-
cation training concerning cultural sensitivity, as several
ethnical groups experience a taboo on sexuality and STIs
which may influence strategies for PN and PIPT.
Legal barriers Another often mentioned barrier to PIPT
was the legislation. Physicians are only allowed to hand
out medication after personal contact with a patient and
after checking contra-indications such as medicine use
and allergies.
One SHC physician mentioned: “I think we doctors are
stricter in this, as we are responsible and liable for pre-
scription of medication. We have the legal situation in
mind. Nurses may be more pragmatic, but I feel strongly
responsible and do think that we cannot just do some-
thing with medication”(SHC physician, female, Dutch).
Physicians feared liability issues when giving (a pre-
scription for) extra antibiotics for partners without
knowing possible contra-indications or for someone not
being their patient.
Medical barriers Various medical safety concerns were
mentioned by the professionals. First, physicians feared
giving extra antibiotics for partners without knowing
possible contra-indications:
‘The risk something goes wrong, is not high, but still I
wouldn’t want to take the risk, as it could have some
consequences. I don’t see other ways than checking aller-
gies and contra-indications for Azithromycin. Although I
realize that PIPT will lower the threshold and a larger
number of chlamydia cases will be treated’ (GP, female,
Dutch).
The question was also raised how the prescription
would be written in the partners’ patient file, and how
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medication would be delivered. Furthermore, profes-
sionals noted that handing out extra antibiotics, without
consultation, feels like incomplete care. Partners might
not be infected with chlamydia at all, might have an ano-
rectal chlamydia infection or have other STIs, requiring
different treatment. Use of PIPT might in this case offer
a false sense of security and lead to untreated infections:
‘Some GPs hand out extra pills when there’s a high risk
the patient won’t notify the partner. But it’s better to no-
tify the partners, so that they have the possibility to
choose for a proper test, as there could be other STIs’
(GPA, female, Dutch).
Also mentioned was the importance of testing and
counselling the partner to determine whether the part-
ner was infected, or might have infected other sex part-
ners. Several professionals also wondered whether
patients and partners will change their sexual behaviour
when antibiotics are handed out without counselling. Es-
pecially professionals from SHC preferred counselling
on STI and sexual behaviour before handing out
antibiotics:
‘It’s a missed opportunity if the partner receives the
medication through the patient and learns nothing from
it’(SHC physician, female, Dutch).
Last, the need for careful use of antibiotics and avoid-
ing overtreatment and potential risk of antibiotic resist-
ance was mentioned by several physicians.
Facilitators for PIPT
The professionals also posed several ideas that could fa-
cilitate the use of PIPT. GPs indicated to need more
than their usual consultation time for STI-patients. As a
GPA says: ‘When you have two minutes consultation
time left, you tend to work towards a conclusion. So the
limited time makes it difficult’(GPA, female, Turkish). Re-
ferring STI-patients to the GPAs for additional counsel-
ling and discussion of PN and PIPT could also solve this
problem. Another facilitator for providing PIPT would
be to enable (phone)-contact with the partner to inquire
about allergies and medication before handing out medi-
cation for the partner to the index-patient. The possibil-
ity of a hot line for partners to discuss their questions
with a health care professional was also perceived as
helpful.
Furthermore, most professionals regarded an STI test
prior to PT essential. Facilitating STI testing of the part-
ner would therefore also facilitate the use of PIPT among
professionals. Even when partners after taking samples
at home would wait for the test results before taking the
medication, the period between treating the patient and
partner would be less than when they have to make an
appointment. Home-based testing could be used to-
gether with PIPT where the partner is given a home
based sampling test-kit via the index and sends the
sample to the SHC to receive their results. This would
also provide partners a feeling of anonymity.
‘People don’t have to go anywhere and they can decide
for themselves where and when they do the test’ (SHC
physician, male, Dutch).
Last, professionals indicated that if PIPT were to be
implemented, they would like to receive proper training
in its use and information on how and for whom it
should be available.
Quantitative survey
The overall response rate of the quantitative survey was
36% (115/321). The 115 respondents were from 23 out
of 24 SHC. 32% (80/248) of the nursing staff responded
and 48% (35/73) of the physicians. Hardly any differ-
ences were seen between answers of physicians and
nurses therefore the overall responses are reported. Only
84 out of the 115 respondents completed the whole sur-
vey, resulting in a complete response rate of 26% (84/
321). Partially completed questionnaires were included
in the analyses.
Current practice of PN and PT
PN is discussed with the index-patient during the treat-
ment consultation. SHC employ different methods of
informing patients about their STI test results. On clinic
level, 26% (6/23) send a text-message to the patient
about the result; 30% (7/23) phone the patient, 13% (3/
23) do both text-message and phone-call and 30% (7/23)
provide patients a code to login and view their results
on the clinic website. 57% (17/30) of professionals of
clinics who phone the patient about results directly offer
a double consultation for the patient and partner. This
percentage was 29% (11/38) and 7% (2/31) in clinics
working with text-message and login codes respectively.
Assessment of the current practice of PT showed that
almost all professionals adhere to the current guidelines.
When partners are presenting at the clinic for consult-
ation, 97% (97/100) of professionals treat the current
partner immediately, and also take an STI test. Only 3%
(3/91) of professionals stated to use PIPT for the current
partner (but not ex-partners) when knowing that the
partner does not have contra-indications.
Considerations for potential implementation of PIPT
When asked about the importance of partner treatment,
97% (83/86) of respondents agreed that current steady
partners should get treatment immediately (43% (37/86)
for the casual partners). A much smaller proportion
would consider providing PIPT: 51% (43/84) for a steady
and 8% (7/84) for a casual partner (Fig. 1).
We asked the professionals about their willingness to
provide PIPT in different situations. Professionals were
most likely to consider PIPT if the partner had a high
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risk of chlamydia and a low chance of presenting for a
consultation (45%; 38/84), and when they knew that the
index-patient would inform the current partner (38%;
32/84). Only 11% (9/84) would hand out medication in
cases when the index patient finds it difficult to inform
their partner. The percentage of professionals consider-
ing PIPT for both current and casual partners was rather
low, around 10–12%, even when the professional would
know that the partner had no other partners, or could
estimate that the partner would not have gonorrhoea of
syphilis or HIV infection (Fig. 2).
Conditions for PIPT
Checking for allergies and contra-indications of the part-
ner before prescribing/handing out azithromycin was con-
sidered necessary by 97% (83/86) of the professionals.
When asked via which route this should be done, 62%
(53/86) preferred a personal consultation, 19% (16/86)
thought this could be done by telephone, 13% (11/86)
thought this would be possible by internet and 7% (6/86)
agreed this could be done at the pharmacy.
When asked about potential risks of PIPT, 79% (68/86)
thought it would be risky to provide PIPT as it is un-
known what the index patient will do with it. 49% (42/
86) agreed that PIPT would encourage unnecessary anti-
biotic prescription, increasing the risk of antibiotic
resistance development, while 31% (27/86) disagreed.
Differences in attitude towards conditions for PIPT
among the STI clinic employees are shown in Fig. 3.
Testing for chlamydia in case of providing PIPT was
considered conditional by 77% of professionals, but only
half (54% (45/84)) would also require testing for gonor-
rhoea. 68% (57/84) agreed that PIPT can only be given if
the law would allow this. Clarity about who could pro-
vide medication, to which index-patients, for which part-
ners and how the partner’s medical history can be
checked was considered essential by around 80% of 84
professionals. Last, the majority 81% (68) agreed that
PIPT should be easy in practice.
Discussion
Main findings
PN and selection of partners eligible for presumptive
treatment are prerequisites for PIPT. We found that the
majority of SHC professionals follow the guidelines for
treating current regular partners presenting at their
clinic. Professional attitudes and competencies as well as
partner characteristics and cultural backgrounds of pa-
tients explain barriers in PN and PT. In general, both
GP-practice and SHC professionals were on one hand
convinced that PIPT would have many advantages such
as preventing re-infections, but on the other hand were
Fig. 1 Differences in attitude towards (patient initiated) partner therapy for steady and casual partners among Dutch SHC employees
Fig. 2 Attitude towards potential implementation of EPT for different types of partners and situations among Dutch SHC employees
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critical and reluctant towards PIPT without counselling
and testing.
Strengths and limitations
A drawback of the quantitative study is the relatively low
response rate of the internet questionnaires. This could
have led to biased results. However, many of the findings
from the qualitative interviews were confirmed by the
questionnaire, which contributes to the reliability of our
results. The combination of the qualitative interviews
followed by an internet survey among SHC staff is thus
a strength of this study. Furthermore, the interviews in-
cluded multiple kinds of sexual health care professionals
from large cities and rural areas all over the country. A
limitation is that the focus groups in this study are
homogenous groups of Dutch professionals. All partici-
pants that were interviewed have special interest in STIs
in their work and may therefore be particularly
favourable for innovative ideas, and not be representa-
tive for all professionals. However, this limitation is also
a strength of this study as these professionals have ex-
pertise and insight in the policy, legislation and treat-
ment of STIs and may be the innovators in case of
implementation of PIPT [20].
We interviewed experienced peer educators in the
field of sexual health care from various cultural back-
grounds. A limitation is that these key-informants on
ethnical and cultural sensitivity are expressing both their
professional and personal views, which may be biased.
However, cultural sensitivity is important when choosing
a strategy for PN, PT and PIPT, and therefore this theme
requires and deserves more research.
Comparison to other countries and studies
Practice of PN
PN is a condition for PIPT. It is therefore not sur-
prising that perceived barriers concern PN and coun-
selling in the first place. Professionals combine several
strategies for discussing PN with their patients, which
they perceived as supportive and effective. Especially
motivational interviewing helps patients to formulate their
own needs and possible solutions. There is room for
improvement with regard to counselling competencies of
GPs [21]. A difference between professionals at GP prac-
tices and SHC is that the latter are used to address sexual
health in a neutral way and use motivational interviewing
[22–24], while some GPs seem to show uneasiness in
discussing sexual health and use authoritative and judging
manners in communication with patients.
Although it was previously found that (intimate) part-
ner violence was not a major concern for PN and PIPT,
this may deserve attention in specific groups [25, 26].
This is exemplified by the anecdotal quote of a GP pro-
viding a prescription also for the partner who may be
prone to violence, realising that the patient may admin-
ister the pills secretly.
PT and PIPT
A prerequisite for PIPT is selection of partners eligible
for presumptive PT. In both the qualitative and the
quantitative study we found that the guidelines for treat-
ing current regular partners are followed once partners
do present in care, however current casual partners are
less often treated. Also many partners present with a
delay after treatment of the index patient. SHC inform
patients about their test results by phone, text-message
or with a code to check the results on the internet. It ap-
peared that the more personal contact a SHC has when
informing the index-patient, the earlier PN, testing and
treatment is discussed. Here the personal approach in
smaller clinics is advantageous as compared to creating
efficiency in large clinics [27].
In both studies we found that professionals agreed that
PT should be improved and that PIPT would be sup-
portive in prevention of chlamydia re-infections in pa-
tients. When assessing barriers for PIPT we found three
main themes: legal and medical arguments and issues
concerning assessment of risk profiles of partners.
Fig. 3 Attitudes towards conditions for potential implementation of EPT among Dutch SHC employees
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Legal arguments
Similar to previous studies, physicians were concerned
about obeying the law, and feared liability problems, for
example when treating persons who are not their own
patients [28, 29].
In the Netherlands it is required prior to prescription
of medication that the physician has contact with the
partner, assesses the medical history (allergies and
contra-indications) and explains the reason for prescrip-
tion. Not all physicians may be fully aware of the legal
situation. PIPT is prescribed by GPs in 4–6% of patients,
mostly for partners who are patients in the same prac-
tice [30]. Whether the partner is informed about the rea-
son for prescription is unclear as is whether GPs are
fully aware of legal requirements. It has been reported
before that professionals who are given instructions
about the legal impossibilities are reluctant in the use of
PIPT, while those not exactly knowing what is allowed
had used PIPT increasingly [31].
Respondents stressed that it should be very clear what
is allowed with respect to PIPT before they would use it,
which is in correspondence with findings in other stud-
ies [28, 29, 31, 32].
Medical arguments
Professionals considered a personal consultation with part-
ners imperative, for evaluation of medical history and for
preventive messages. Despite agreement that PT should be
provided to current partners, the percentage of profes-
sionals who would use PIPT was much lower. This reluc-
tant attitude can be explained by the responsibility they felt
about the safety of partners and the concern whether medi-
cation would reach the right person and whether the
adequate medication would be provided, for example
because anal infections should be treated with Doxycycline
instead of Azithromycin. Similar medical concerns have
been reported before [31–33]. Another concern was poten-
tial side effects of Azithromycin, although respondents
acknowledged that in fact side effects would be scarce. No
serious adverse effects have been reported from Azithromy-
cin associated with EPT trials or subsequent surveillance in
the US, leading to the suggestion that jurisdictions should
endorse EPT [34]. These medical arguments could be
counteracted by APT, where contact with a partner is a
condition met.
Although PIPT might have beneficial effects, there were
concerns about the missed opportunity to screen a high-
risk population for STI other than chlamydia [35, 36]. A
part of the PICC-UP study was the assessment of STI in
SHC clients who were notified for chlamydia. Treating
them without gonorrhoea testing would miss 10 % of gon-
orrhoea in this high risk population [37]. Partner testing
was perceived as highly important for using PIPT. Combin-
ing testing and treating would reduce the delay in PT.
Providing a home based test kit for the partner may even
facilitate PN as the index-patient has something to offer,
and would prevent unnecessary use of antibiotics when a
partner would wait for the result [38]. If the partner has an
STI, PN can be extended to the sex-network of the partner.
Assessment of risk profiles of partners
Only one in ten SHC professionals would provide PIPT
when estimating that the partner has no other partners
or STIs. This may be due to the difficulties in estimating
risk profiles of partners. Patients do not necessarily
know what their partners do. It is therefore understand-
able that professionals regard personal contact with the
partner essential. Having telephone contact with part-
ners has been found as a facilitator for PIPT before [6]
but contacting a partner during the treatment consult-
ation may pose logistic problems. Options like a hotline
as in APT may be a possibility [11]. Only few profes-
sionals were open for assessing the medical history by
internet. Provided that this is legally allowed in SHC, an
online service combined with traditional service as
described recently may be the way forward [39].
Conclusions and recommendations
Physicians and nurses from SHC and GP practice staff
found PT for chlamydia important, but their attitude to-
wards PIPT was reluctant. PIPT could be considered for
steady partners or for partners who may not present for
testing, but contact with the partner is deemed essential.
Partner testing was perceived as an important condition
for using PIPT. Thus a form of APT could be the way to
go. APT in combination with home based testing and
using e-healthcare should be further explored and devel-
oped. Before implementing APT, improving PN and
counselling skills with specific focus on cultural sensitiv-
ity is needed.
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